Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for ...

--(BUSINESS WIRE)--Cognito Therapeutics, a clinical-stage company leading the development of a new class of disease-modifying digital therapeutics to treat neurodegenerative disorders, announced ...

One startup is testing whether a "disco" of light and sound can slow the disease in patients. Cognito Therapeutics raised $73 million to test this theory in hundreds of people. For decades ...

Dr. Rick Kuntz, former Senior Vice President, Chief Medical and Scientific Officer at Medtronic, joins Cognito Board of Directors. CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics ...

The series B round adds $73 million to Cognito’s coffers, the startup announced Wednesday. It’ll go toward the ongoing pivotal study of the noninvasive headset, which relies on light waves and ...

Cognito’s analysis compared participants treated in the Overture study, which enrolled 76 people, to historical data collected from a separate, decade-long, global study conducted by the ...